Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering-Plough Clear Passage nasal dilator strips "from the Afrin brand" shipping Aug. 1.

This article was originally published in The Tan Sheet

Executive Summary

SCHERING AFRIN CLEAR PASSAGE NASAL STRIPS SHIPPING AUG. 1 under a licensing agreement between Schering-Plough and Inglewood, Calif.-based Acutek Adhesive Specialties. Unlike the competing product Breathe Right from CNS, Clear Passage strips appear to be trying, in part, for a narrower niche as an adjunct to other nasal congestion therapies. Schering is positioning Clear Passage nasal strips as providing "drug free instant relief" of the "symptoms of nighttime nasal congestion." Clear Passage strips have a "contoured design for comfort," packaging notes.

You may also be interested in...



CNS Fiberchoice Chewable Supplement Launching In Spring

Nasal strip maker CNS is expanding into the nutritionals market with Fiberchoice, a new chewable fiber tablet set to launch nationwide in April.

CNS Fiberchoice Chewable Supplement Launching In Spring

Nasal strip maker CNS is expanding into the nutritionals market with Fiberchoice, a new chewable fiber tablet set to launch nationwide in April.

CNS Fiberchoice Chewable Supplement Launching In Spring

Nasal strip maker CNS is expanding into the nutritionals market with Fiberchoice, a new chewable fiber tablet set to launch nationwide in April.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088683

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel